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ABSTRACT
Background. Advanced chronic kidney disease (CKD) is asso-
ciated with the development of renal metabolic acidosis. Meta-
bolic acidosis per se may represent a trigger for progression of
CKD. Renal acidosis of CKD is characterized by low urinary
ammonium excretion with preserved urinary acidiﬁcation in-
dicating a defect in renal ammoniagenesis, ammonia excretion
or both. The underlying molecular mechanisms, however,
have not been addressed to date.
Methods. We examined the Han:SPRD rat model and used a
combination of metabolic studies, mRNA and protein analysis
of renal molecules involved in acid–base handling.
Results. We demonstrate that rats with reduced kidney
function as evident from lower creatinine clearance, lower
haematocrit, higher plasma blood urea nitrogen, creatinine,
phosphate and potassium had metabolic acidosis that could be
aggravated by HCl acid loading. Urinary ammonium excretion
was highly reduced whereas urinary pH was more acidic in
CKD compared with control animals. The abundance of key
enzymes and transporters of proximal tubular ammoniagen-
esis (phosphate-dependent glutaminase, PEPCK and SNAT3)
and bicarbonate transport (NBCe1) was reduced in CKD com-
pared with control animals. In the collecting duct, normal ex-
pression of the B1 H+-ATPase subunit is in agreement with
low urinary pH. In contrast, the RhCG ammonia transporter,
critical for the ﬁnal secretion of ammonia into urine was
strongly down-regulated in CKD animals.
Conclusion. In the Han:SPRD rat model for CKD, key mole-
cules required for renal ammoniagenesis and ammonia excre-
tion are highly down-regulated providing a possible molecular
explanation for the development and maintenance of renal
acidosis in CKD patients.
Keywords: acidosis, ammoniagenesis, CKD
INTRODUCTION
Metabolic acidosis is common in chronic kidney disease (CKD)
and is associated with several complications such as muscle
wasting, impaired growth in children, bone disease, hypo-
albuminaemia, inﬂammation and insulin resistance. Moreover,
it has been associated with increased mortality in dialysis and
non-dialysis-dependent CKD patients [1–5]. Numerous recent
studies particularly highlighted the role of metabolic acidosis in
the progression of CKD and the increased risk to develop end-
stage renal disease [6–9]. The mechanisms of metabolic acidosis
in CKD were ﬁrst functionally investigated >50 years ago and it
was shown that patients with metabolic acidosis and CKD dem-
onstrate reduced excretion of ammonium, the most important
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buffer for renal acid excretion and bicarbonate synthesis, with
preserved ability to acidify urine [10–13]. However, the affected
molecular pathways in the development of metabolic acidosis in
CKD have not been addressed to date.
Hannover rat (Han:SPRD) is a commonly used model for
autosomal dominant polycystic kidney disease, although the
disease is caused by a mutation in the Pkdr1 gene and no mu-
tations are found in humans with polycystic kidney disease.
Heterozygous male (cy/+) animals are characterized by a slow
progression of kidney disease and proteinuria [14, 15]. Conse-
quently, these rats have also been used as a model for CKD
[16, 17].
Renal ammoniagenesis and ammonium excretion depend
on a complex interplay between different nephron segments
[18–21]. Ammoniagenesis in the proximal tubule serves mostly
the de novo synthesis of bicarbonate to replenish bicarbonate
buffers used by metabolism. Glutamine is taken up by proximal
tubule cells, most likely by the SNAT3 amino acid transporter
and metabolized by a series of enzymes located in mitochondria
and cytosol. Phosphate-dependent glutaminase (PDG) and glu-
tamate dehydrogenase (GDH) release two ammonia (NH3) mo-
lecules and one bicarbonate (HCO3
−) ion whereas further
metabolism of the resulting α-ketoglutarate by the phospho-
enol pyruvate carboxy kinase (PEPCK) generates an additional
HCO3
− ion. The process of proximal tubular ammoniagenesis is
highly stimulated during acidosis or by acid load [21, 22]. Am-
monium (NH4
+) produced by the proximal tubule is mostly re-
leased into urine and is partly reabsorbed at the level of the
thick ascending limb of the loop of Henle, concentrated in the
medullary interstitium and secreted into urine [18–20]. The
ﬁnal secretory step depends on the capacity of H+-ATPases to
acidify urine and the RhCG ammonia transporter [18, 19, 23].
Here, we used the Han:SPRD rats as a CKDmodel and inves-
tigated the regulation of key molecules in renal acid–base hand-
ling to identify the molecular mechanisms that contribute to the
development of metabolic acidosis in CKD. Our data demon-
strate a strongly reduced expression of enzymes and transporters
involved in proximal ammoniagenesis and ammonia secretion
whereas the capacity to acidify urine was preserved. Thus, our
data suggest that metabolic acidosis is caused by the kidneys’ im-
paired ability to produce and excrete adequate ammonium
amounts thereby impairing bicarbonate synthesis and metabolic
acid buffering.
MATERIALS AND METHODS
Animal model
The study was conducted in 4-month-old male heterozy-
gous (cy/+) and wild-type (+/+) littermate Han:SPRD rats.
Rats received standard diet (Provimi Kliba S.A., Switzerland)
at Days 1 and 2, and consecutively HCl diet (500 g standard
diet mixed with 750 mL of 333 mM HCl) to induce an add-
itional acid-loader wet standard diet (analogously mixed with
distilled water) for 2 days (Days 3 and 4). Rats were placed into
metabolic cages on Day 1 for adaptation. Water and food
intake as well as body weight were measured daily, and 24-h
urine (under mineral oil) and stool were collected. All animal
experiments were performed according to national and inter-
national guidelines and laws of animal welfare and protocols
approved by the local Veterinary Authority (Veterinäramt,
Zürich, Switzerland). At the end of the experiments, rats were
anaesthetized with isoﬂurane, heparinized blood was collected
from the tail artery, and animals were perfused with PBS
(136.9 mM NaCl, 2.68 mM KCl, 10 mM Na2HPO4, 1.76 mM
KH2PO4, pH 7.4 with HCl) to remove blood. Kidneys were
immediately removed and subsequently snap-frozen in liquid
nitrogen and stored at −80°C until further analysis.
Blood and urine analysis
Rats were anaesthetized with isoﬂurane (IsoFlo®, Abbott
AG, Baar, Switzerland), 1.5–2.0%, and heparinized blood was
collected from the tail artery and analysed immediately for pH,
blood gases and electrolytes on a Radiometer ABL 800 Flex
blood gas analyser (Radiometer, Copenhagen, Denmark) on
Days 2, 3 and 5. In addition, at the end of the experiment (Day
5), blood was taken from the left ventricle and the inferior caval
vein to measure plasma creatinine, phosphate, blood urea ni-
trogen (BUN), glucose and albumin using the clinical chemis-
try analyser Piccolo® Xpress (Abaxis, Union City, CA, USA).
Ion chromatography (Metrohm ion chromatograph, Herisau,
Switzerland) was performed to determine urinary Na+, K+ and
Cl− concentrations. Urine pH, pCO2 and calculated HCO3
−
were determined by aspirating urine from the collectors into
gas-tight syringes and injecting it into the blood gas analyser.
Urinary creatinine was analysed using the Jaffé method [24,
25]. Urinary ammonium concentration was determined using
the Berthelot protocol [26]. Urinary phosphate was measured
by standards of Urine Precision Controls (Randox Lab, UK).
Creatinine clearance was calculated from the measured values.
RNA extraction
Approximately 25 mg of snap-frozen kidney tissue was
homogenized in RLT-Buffer (Qiagen, Hilden, Germany) sup-
plemented with 2-mercaptoethanol to a ﬁnal concentration of
1%. Total RNA was extracted from 600 μL of each homoge-
nized sample using the RNeasy Mini Kit (Qiagen) according
to the manufacturer’s instructions. DNase digestion was per-
formed using the RNase-Free DNase Set (Qiagen). Quality,
purity and concentration of the isolated RNA preparations
were analysed spectroscopically using the ND-1000 spectro-
photometer (NanoDrop Technologies, Wilmington, DE,
USA). Total RNA samples were stored at −80°C.
Semi-quantitative real-time RT-PCR
The RNA samples were diluted to 100 ng/μL. First, reverse
transcription was performed using the TaqMan Reverse Tran-
scription Reagents (Roche Molecular Systems, Branchburg,
NJ, USA/Applied Biosystems, Foster City, CA, USA). Brieﬂy,
12.4 μL RNase-free water, 4 μL 10× RT buffer, 8.8 μL MgCl2
solution, 2 μL random hexamers, 8 μL dNTP mixture, 0.8 μL
RNase inhibitor and 1 μL MultiScribe Reverse Transcriptase
(respectively, 1 μL of additional RNase-free water for negative
controls) were mixed with 3 μL of RNA to perform reverse
transcription by using the Tpersonal Combi thermocycler
(Biometra, Göttingen, Germany) with thermo-cycling
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conditions set at 25°C for 10 min, 48°C for 30 min and 95°C
for 5 min. Next, relative mRNA expression was determined
using quantitative real-time PCR with the 7500 Fast Real-
Time PCR System (Applied Biosystems) on the basis of the
standard 7500 run mode. Primers for all genes of interest were
designed using Primer3-web software (frodo.wi.mit.edu/
primer3) (see Supplementary Table 1). Probes of the tested
genes were labelled with the reporter dye FAM at the 50 end
and the quencher dye TAMRA at the 30 end (Microsynth,
Balgach, Switzerland). The probe of the housekeeping gene rat
18S rRNA (Applied Biosystems) was labelled with the reporter
dye VIC at the 50 end and the quencher dye TAMRA at the 30
end. The speciﬁcity of all primers was ﬁrst tested in a standard
PCR and always resulted in a single product of the expected
size on 1.5% agarose gels (data not shown). Brieﬂy, 2 μL
cDNA, 0.8 μL of each primer (25 μM), 0.4 μL labelled probe
(5 μM), 6 μL RNase-free water and 10 μL TaqMan Universal
PCR Master Mix (Applied Biosystems) reached 20 μL of ﬁnal
reaction volume for the tested gene. The protocol for the
housekeeping gene was slightly different: 2 μL cDNA, 1 μL of
the human 18S rRNA (20×) Control primers and probe
reagent, 7 μL RNase-free water and 10 μL TaqMan Universal
PCR Master Mix. Reaction conditions were denaturation at
95°C for 10 min followed by 40 cycles of denaturation at 95°C
for 15 s and annealing/elongation at 60°C for 60 s with auto-
ramp time. All reactions were run in triplicates, including a
negative control. To analyse the data, we set the threshold to
0.06 as this value had been determined to be in the linear
range of the ampliﬁcation curves for all mRNAs in all experi-
mental runs. The expression of gene of interest was calculated
in relation to Human 18S rRNA. Relative expression ratios
were calculated as R¼ 2[Ctð18SÞ Ctðgene of interest)], where
Ct represents the cycle number at the threshold 0.06.
Western immunoblotting
For immunoblotting brush border membrane (BBM) pro-
teins were prepared using the Mg2+ precipitation technique
[27]. Additionally, protein extraction of total membrane frac-
tions (MF) of kidney tissue was performed. Brieﬂy, kidney
tissue was homogenized in ice-cold HEPES buffer (200 mM
mannitol, 80 mM HEPES, 41 mM KOH, titrated with KOH to
pH 7.5) with Protease Inhibitors Cocktail Tablets complete,
Mini (Roche Diagnostics GmbH, Mannheim, Germany). Both
BBM and MF protein samples were used for western blotting.
After measurement of the protein concentration (Bio-Rad Dc
Protein Assay, Bio-Rad, Hercules, CA, USA), 40 μg of MF
protein or 20 μg of BBM protein was solubilized in Laemmli
sample buffer, and SDS–PAGE was performed on 8–10%
polyacrylamide gels. Proteins were transferred electrophoretic-
ally from gels to polyvinylidene diﬂuoride membranes (Immo-
bilon-P, Millipore, Bedford, MA, USA). After blocking with
5% milk powder in Tris-buffered saline containing 0.1% (v/v)
Tween-20 for 60 min at room temperature, the blots were in-
cubated with the respective primary antibodies overnight at 4°
C or 2 h at room temperature (see Supplementary Table 2).
Antibodies against SNAT3 produced two bands, a speciﬁc
band of ∼55–60 kDa and an unspeciﬁc band of lower molecu-
lar weight of ∼40 kDa. PDG appears as two bands of 66 and
68 kDa and both bands were quantiﬁed together [28]. Similar-
ly, pendrin antibodies recognized two speciﬁc bands of ∼100
and 150 kDa [29].
After washing and subsequent blocking, blots were incu-
bated with the secondary antibody [donkey anti-rabbit or
sheep anti-mouse antibodies linked to horseradish peroxidase
1 : 10 000 (GE Healthcare, Little Chalfont, Buckinghamshire,
UK) or goat anti-rabbit and goat anti-mouse antibody 1 : 5000
linked to alkaline phosphatase (Promega, Madison, WI, USA)]
for 1 h at room temperature. Antibody binding was detected
with appropriate Immobilon Western chemiluminescence
substrates (Millipore, Billerica, MA, USA), using the LAS-
4000 Luminescent Image Analyzer (Fujiﬁlm, Tokyo, Japan).
All images were analysed using appropriate software (Ad-
vanced Image Data Analyzer version 3.44, Raytest) to calculate
the protein of interest/actin ratio.
Statistical analysis
All data are presented as means ± SE. Unpaired two-tailed
t-test or ANOVA with Bonferroni correction were applied for
inference statistics and result with P-value <0.05 were consid-
ered statistically signiﬁcant.
RESULTS
Han:SPRD cy/+ rats recapitulate hallmarks of CKD and
develop severe hyperchloraemic metabolic acidosis
Cy/+ compared with +/+ rats receiving standard diet had
lower blood bicarbonate, higher chloride and reduced pCO2
levels indicating a partly compensated hyperchloraemic meta-
bolic acidosis. Potassium and phosphate plasma levels were
elevated and creatinine clearance and haematocrit were lower
demonstrating advanced CKD (Tables 1 and 2) in cy/+ rats.
Urine analysis showed more acidic urine, lower urinary bicar-
bonate and higher phosphate excretion in cy/+ compared with
+/+ rats whereas ammonium excretion was similar between
groups (Table 2). Thus, cy/+ rats display the major hallmarks
of advanced CKD conﬁrming and expanding previous reports
[30, 31].
Next, we tested the rats’ ability to respond to an additional
acid load by adding HCl to food for 48 h. Arterial blood gas
analysis conﬁrmed induction of metabolic acidosis in HCl-
treated animals (Table 1). However, cy/+ rats developed a
more severe metabolic acidosis compared with +/+ littermates
(blood pH 7.13 ± 0.00 versus 7.34 ± 0.01). Accordingly, arterial
bicarbonate levels were lower in cy/+ animals compared with
+/+ rats (8.3 ± 0.4 versus 15.6 ± 0.3 mmol/L). These results
indicate that cy/+ animals’ ability to buffer an acid load is
impaired. Interestingly, induction of acidosis was associated
with a fall in creatinine clearance in both wild-type and cy/+
animals (Table 2).
The dietary acid load caused a markedly acidic urinary pH
in both cy/+ and +/+ rats (Table 2). Thus, cy/+ rats with mark-
edly reduced renal function were also able to acidify urine to
the same extent as wild-type animals with normal renal func-
tion. Similarly, patients with advanced CKD maintain their
ability to acidify urine [10, 12] suggesting that the Han:SPRD
O
R
IG
IN
A
L
A
R
T
IC
L
E
772 R. Bürki et al.
rat model serves as a useful CKD model for studying metabolic
acidosis.
After acid load urinary ammonium excretion, a major com-
ponent of overall net acid excretion, was signiﬁcantly lower in
cy/+ compared with +/+ rats (Table 2) whereas, urinary phos-
phate excretion, a major component of titratable acidity, in-
creased modestly in both animal groups. Our data suggest that
urinary acidiﬁcation is preserved in CKD animals whereas
urinary ammonium excretion is decreased by ∼60–80% which
is paralleled by more severe metabolic acidosis.
Expression of ammoniagenic key molecules is reduced in
CKD rats
We performed real-time RT-qPCR on kidney tissue for
SNAT3, PDG, PEPCK and the sodium/proton exchanger Type
3 (NHE3), key molecules of the renal ammoniagenesis
pathway. The mRNA abundance of PEPCK, SNAT3 and
NHE3 was reduced in cy/+ CKD rats (Figure 1) compared
with wild-type animals under standard diet and after 48-h
acid load. In contrast, PDG mRNA expression was increased
after the acid load in cy/+ CKD animals (Figure 1).
Similarly, protein abundance of SNAT3 and PEPCK in cy/
+ animals was markedly decreased compared with wild-type
littermates (Figure 2). PDG protein levels were decreased after
the acid load, opposite to mRNA levels (Figure 2). Protein
levels of NHE3 were not different compared with wild-type
animals (Figure 2).
The electrogenic sodium/bicarbonate co-transporter Type
1 (NBCe1) is located on the basolateral membrane of the prox-
imal tubule cell and releases bicarbonate into blood. mRNA
expression of NBCe1 was decreased in cy/+ CKD animals
under standard diet and increased after acid load (Figure 3).
Protein levels were also decreased under both standard diet
and after the acid load (Figure 3).
Taken together, these data demonstrate a strong reduction
in the expression of key molecules of the ammoniagenesis
pathway in kidneys from cy/+ CKD animals under standard
diet. CKD animals were able to modestly increase urinary am-
monium excretion after acid loading; however, to a much
lesser extent than wild-type animals. Thus, reduced expression
of key molecules of the ammoniagenesis pathway parallels
lower urinary ammonium excretion in CKD rats.
Table 2. Summary of urine parameters from wild-type and cy/+ CKD rats on standard diet or after 2 days of HCl diet
Urine Baseline 24-h HCl diet 48-h HCl diet
WT Cy/+ WT Cy/+ WT Cy/+
pH 6.61 ± 0.03 5.74 ± 0.06*** 5.73 ± 0.03+++ 5.48 ± 0.02***,++ 5.37 ± 0.03+++ 5.29 ± 0.02*,+++
24-h urine/body weight, mL/g 0.09 ± 0.00 0.09 ± 0.01 0.11 ± 0.02++ 0.10 ± 0.01 0.10 ± 0.01 0.12 ± 0.00
Creatinine clearance, mL/min 8.3 ± 0.9 2.5 ± 0.2 n/a n/a 3.68 ± 0.22+++ 0.82 ± 0.08***,+++
Na+, mmol/24 h 1.06 ± 0.12 1.33 ± 0.05 2.64 ± 0.17+++ 1.22 ± 0.10*** 2.18 ± 0.06+++ 1.33 ± 0.14***
K+, mmol/24 h 4.30 ± 0.36 6.77 ± 0.15*** 6.57 ± 0.31+++ 5.99 ± 0.27+ 6.92 ± 0.16+++ 4.50 ± 0.29***,+++
Phosphate, mmol/24 h 0.63 ± 0.03 0.96 ± 0.04*** 1.05 ± 0.08+++ 1.08 ± 0.07 1.18 ± 0.05+++ 1.27 ± 0.07++
NH4
+, mmol/24 h 0.11 ± 0.01 0.07 ± 0.00 3.18 ± 0.22+++ 1.10 ± 0.24***,++ 8.32 ± 0.25+++ 1.71 ± 0.09***,++
HCO3
−, mmol/24 h 5.78 ± 0.44 1.17 ± 0.13*** 0.29 ± 0.04+ 0.39 ± 0.03++ 0.18 ± 0.02+++ 0.22 ± 0.01+++
Values are means ± SE; n = 3–6 animals/group.
*,+P < 0.05, **,++P < 0.01, ***,+++P < 0.001, *signiﬁcantly different between wild-type and CKD rats (cy/+) for the same time point, +signiﬁcantly different between baseline and/or 24-h
HCl and/or 48-h HCl diet for the same genotype.
Table 1. Summary of arterial blood parameters from wild-type and cy/+ CKD rats on standard diet or after 2 days of HCl diet
Blood Baseline 48-h HCl diet
WT Cy/+ WT Cy/+
pH 7.45 ± 0.01 7.44 ± 0.01 7.34 ± 0.01+++ 7.13 ± 0.00***+++
pCO2, mmHg 36.9 ± 1.1 31.3 ± 0.3** 30.1 ± 0.6
++ 26.3 ± 1.2*++
pO2, mmHg 90.9 ± 1.4 93.4 ± 1.4 96.7 ± 1.1
++ 95.3 ± 4.3
HCO3
−, mM 25.2 ± 0.7 20.6 ± 0.2*** 15.6 ± 0.3+++ 8.3 ± 0.4***+++
SO2, % 95.4 ± 0.3 95.6 ± 0.2 95.2 ± 0.1 93.3 ± 0.8*
Haematocrit 43.9 ± 2.9 40.6 ± 2.1** 46.0 ± 0.6 37.3 ± 0.7***
Sodium, mM 139.0 ± 1.0 137.0 ± 0.4 145 ± 2+ 145 ± 4+
Potassium, mM 3.8 ± 0.1 4.7 ± 0.1** 5.4 ± 0.2++ 5.4 ± 0.3
Chloride, mM 100.0 ± 1.0 103 ± 1.0* 106 ± 1***++ 115 ± 2**+++
Phosphate, mg/dL 6.8 ± 0.2 7.9 ± 0.3** 6.9 ± 0.1 8.3 ± 0.4**
Creatinine, mg/dL 0.3 ± 0.0 0.7 ± 0.0 0.3 ± 0.0 1.3 ± 0.1***++
BUN, mg/dL 15 ± 1 43 ± 2*** 14 ± 1 48 ± 3***
Albumin, g/dL 1.8 ± 0.1 1.8 ± 0.0 1.9 ± 0.0 1.7 ± 0.1**
Glucose, mg/dL 247 ± 18 197 ± 3* 220 ± 7 173 ± 5***++
Values are means ± SE; n = 5–6 animals/group.
*,+P < 0.05, **,++P < 0.01, ***,+++P < 0.001, *signiﬁcantly different between wild-type and CKD rats (cy/+) at the same time point, +signiﬁcantly different between baseline and 48-h HCl
diet for the same genotype.
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Sodium-dependent phosphate transporters are altered in
CKD rats
The major renal phosphate transporters NaPi-IIa and
NaPi-IIc and the third sodium-dependent phosphate trans-
porter Pit-2 are expressed on the apical membrane of the prox-
imal tubule cells and mediate phosphate reabsorption [32].
mRNA abundance of NaPi-IIa and NaPi-IIc was decreased
during standard diet and after acid loading in cy/+ rats com-
pared with control rats (Figure 4) while Pit-2 mRNA expression
was not altered. BBM protein levels of the three phosphate
transporters were regulated differently. NaPi-IIc protein abun-
dance was decreased while NaPi-IIa and Pit.2 remained un-
changed. However, after an acid load, Pit-2 protein levels were
increased (Figure 5).
Ammonium excretion is reduced in CKD rats
The last set of experiments examined the abundance of pro-
teins contributing to ﬁnal urinary acidiﬁcation and ammonium
excretion along the collecting duct system: the Type A interca-
lated cell speciﬁc AE1 anion exchanger, the non-Type A inter-
calated cell marker pendrin, the ammonia transporter RhCG,
and the B1 subunit of the H+-ATPase enriched in intercalated
cells [23]. The mRNA abundance of AE1 was decreased in
CKD animals while B1 mRNA abundance was markedly in-
creased after acid loading compared with wild-type animals
(Figure 6). RhCG and pendrin mRNA abundance was not dif-
ferent. AE1 protein levels were reduced in CKD rats while B1
protein levels were unchanged in comparison to wild-type rats
(Figure 7). RhCG protein abundance was strongly decreased
under standard diet and after acid loading compared with
wild-type animals. Thus, normal H+-ATPase expression and
reduced RhCG abundance are consistent with the preserved
urinary acidiﬁcation and reduced ammonium excretion in
CKD rats.
DISCUSSION
Metabolic acidosis is a common complication of CKD and is
associated with increased mortality in dialysis and non-dialy-
sis-dependent CKD patients. Particularly, the impact of meta-
bolic acidosis on the progression of CKD and the increased
risk to develop end-stage renal disease have been recently
highlighted by studies investigating the effect of alkali supple-
mentation as a potential nephroprotective treatment in pa-
tients with CKD [3, 4, 6–9].
The major ﬁndings in our study are (i) cy/+ Han:SPRD rats
mimic major features of CKD, (ii) metabolic acidosis in this
CKD rat model is paralleled by the reduced expression of key
molecules of proximal tubular ammoniagenesis, (iii) urinary
acidiﬁcation and expression of H+-ATPases in the collecting
duct are preserved, (iv) the RhCG ammonia transporter re-
quired for ﬁnal urinary excretion of ammonium is down-
regulated and (v) renal phosphate reabsorption was reduced in
CKD rats.
Han:SPRD rats mimic features of CKD
Humans with CKD have reduced glomerular ﬁltration rate
(GFR) and develop several complications such as anaemia,
F IGURE 1 : Reduced mRNA expression of key ammoniagenic molecules in kidneys from CKD rats. Normalized mRNA abundance of PEPCK,
SNAT3, PDG and NHE3 in kidneys from controls and CKD rats (cy/+) under standard diet and 2 days of acid load with HCl. n = 5–6 per group,
*P < 0.05, **P < 0.01, ***P < 0.001 signiﬁcantly different between wild-type and CKD rats (cy/+).
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F IGURE 2 : Altered expression of key molecules of ammoniagenesis in kidneys from CKD rats. Protein abundance of PEPCK, SNAT3, PDG
and NHE3 are shown in controls and CKD rats (cy/+) on standard diet and after 2 days of acid load with HCl. The immunoblots were stripped
and re-probed for all proteins and β-actin. All data were normalized against β-actin. n = 5–6 per group, *P < 0.05, **P < 0.01, ***P < 0.001 signiﬁ-
cantly different between wild-type and CKD rats (cy/+).
F IGURE 3 : Altered expression of the proximal tubular bicarbonate transporter NBCe1. Normalized mRNA and protein abundance of NBCe1
are shown in controls and CKD rats (cy/+) on standard diet and after 2 days of acid load with HCl. Immunoblots were normalized against β-
actin. n = 5–6 per group, *P < 0.05, **P < 0.01, ***P < 0.001 signiﬁcantly different between wild-type and CKD rats (cy/+).
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metabolic acidosis, mineral bone disease, neuropathy etc. with
progressive disease [33]. Similarly, cy/+ rats presented with CKD
conﬁrmed by elevated creatinine and BUN values in blood and
reduced creatinine clearance. Cy/+ rats also had metabolic acid-
osis, lower haematocrit, hyperkalaemia and hyperphosphataemia.
These ﬁndings are consistent with and expand previous reports
using this rat strain as model for CKD or polycystic kidney
disease [30, 31]. Acid loading wild-type and cy/+ rats, caused a
fall in creatinine clearance in both groups. The mechanism(s) by
which acidosis may reduce GFR is currently not exactly known.
Metabolic acidosis in CKD is due to reduced expression
of key molecules of ammoniagenesis and decreased
ammonium excretion by the kidney
Patients with CKD and metabolic acidosis maintain their
ability to excrete acidic urine but have a reduced capacity to in-
crease their ammonium excretion [11, 12]. Ammoniagenesis is
markedly reduced in patients with CKD which correlates with
decreased renal metabolism of glutamine [34]. However,
whether reduced total ammoniagenesis reﬂects only a lower
number of nephrons or a decreased capacity of surviving ne-
phrons has been intensively studied in rat models of partial
nephrectomy or infarction [13, 35]. These experiments indi-
cated that the kidneys capacity to produce ammonium was pro-
portional to nephron number, ammoniagenesis could be
stimulated by diet and that a compensatory increase in ammo-
nium producing cells could be found. In our experiments,
urinary ammonium excretion was inappropriately low in CKD
rats and responded only with a small increase to the acid load.
This may result from impaired ammoniagenesis, defective am-
monium excretion or urinary acidiﬁcation, or a combination of
these factors. mRNA abundance and protein expression of
PEPCK and SNAT3 were highly reduced in CKD rats. Add-
itionally, PDG and NBCe1 protein abundance were also
decreased in acid-loaded CKD rats. Of note, the direction of
changes in mRNA expression and protein abundance differed
for NHE3, PDG, NBCe1, NaPi-IIa and Pit-2 for some condi-
tions. The causes for these differences are currently not known
F IGURE 4 : mRNA expression of sodium-dependent phosphate transporters is altered in CKD rats. Normalized mRNA abundance of NaPi-
IIa, NaPi-IIc and Pit-2 are shown in controls and CKD rats (cy/+) on standard diet and after 2 days of acid load with HCl. n = 5–6 per group, *P
< 0.05, **P < 0.01, ***P < 0.001 signiﬁcantly different between wild-type and cy/+ rats.
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but these differences indicate that the interpretation of changes
in mRNA expression without analysis of protein abundance can
be misleading.
SNAT3 is expressed on the basolateral membrane of prox-
imal tubule cells mediating glutamine uptake for ammonia-
genesis [36–38]. Glutamine is further metabolized by a series
of enzymes including PDG, GDH and ﬁnally PEPCK resulting
in the cumulative synthesis of two NH3 and two HCO3
− ions
[21]. Bicarbonate generated during these metabolic steps is re-
leased into blood by the basolaterally located NBCe1 sodium/
bicarbonate co-transporter. Reduced expression of all these
key molecules in the cy/+ CKD rats may severely impair am-
moniagenesis and bicarbonate transport.
We and others have previously shown that many of these
transporters and enzymes investigated here respond with
changes in their expression to endogenous or exogenous acid
loads. The expression of NHE3, NaPi-IIa, PDG, PEPCK,
SNAT3, NBCe1, RhCG and AE1 is increased whereas pendrin
expression decreased in kidneys from acid-loaded kidneys [39–
42]. Here, we compared only control animals versus cy/+ CKD
rats as we wanted to assess how renal impairment impacted on
the ability of the kidney to excrete acid but were not interested
to study the renal response per se to an acid load. However, the
regulation can be inferred from the ratios between control and
Cy/+ CKD animals at baseline and after the acid load showing
that most proteins were up-regulated in the Cy/+ CKD rats with
the acid load as the ratios remain constant, e.g. for SNAT3,
NHE3, NBCe1, NaPi-IIa, NaPi-IIc, AE1, B1 and RhCG. In the
case of pendrin, acid loading reduced pendrin expression in WT
to the same level as in Cy/+ under baseline conditions most
likely reﬂecting the already existing acidosis in CKD rats. In con-
trast, acid loading revealed a strong increase in Pit-2 expression
in CKD rats and reversed a trend to higher expression of PDG
in CKD rats to a lower expression in acid-loaded CKD rats.
We assessed the abundance of these molecules in tissue
homogenates from whole kidneys. Thus, our results do not
directly indicate whether reduced abundance is due to reduced
nephron number or rather due to decreased expression per
nephron. Data from animal models with reduced kidney mass
suggested that the reduced number of functional nephrons
would decrease the total capacity to produce ammonium and
that the rate of ammoniagenesis was even stimulated at the
level of the single nephron [13, 35]. However, our results may
also be interpreted as a down-regulation of key molecules of
ammoniagenesis. Reduced expression was found only for few
molecules such as SNAT3, PEPCK, NBCe1 and NaPi-IIc
whereas other proximal tubule proteins such as NaPi-IIa, Pit2,
NHE3 or PDG remained unaltered or were even up-regulated.
Therefore, the results may suggest that reduced expression of
SNAT3, PEPCK and NBCe1 may be caused by a down-regula-
tion in surviving nephrons. In fact, the degree of metabolic
acidosis found in CKD rats at baseline would cause a strong
up-regulation of these enzymes and transporters in the
healthy kidney [22]. The mechanisms that may induce a spe-
ciﬁc down-regulation of some proximal tubular proteins in-
volved in ammoniagenesis and bicarbonate transport remain
to be identiﬁed. Clearly, this important question warrants
further experiments in this CKD animal model as well as in
additional models to clarify the underlying mechanisms and
whether these mechanisms are model speciﬁc or occur in dif-
ferent models of CKD and also in humans.
F IGURE 5 : Expression of renal sodium-dependent phosphate
transporters in CKD rats. Protein abundance of NaPi-IIa, NaPi-IIc
and Pit-2 are shown in controls and CKD (cy/+) rats on standard diet
and after 2 days of acid load with HCl. The immunoblots were stripped
and re-probed for all proteins and β-actin. All data were normalized
against β-actin. n = 5-6 per group, *P < 0.05, **P < 0.01, ***P < 0.001
signiﬁcantly different between wild-type and CKD rats (cy/+).
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Accumulation of ammonium in the medullary interstitium
is necessary to facilitate excretion into the collecting duct. The
transport of ammonium into the interstitium is mediated by
the Na+/K+/2Cl−, co-transporter NKCC2 and the Na+/H+ ex-
changer NHE4 and may involve interactions with sulphatides
[18, 43, 44]. We tested the expression of NKCC2 and found no
differences between control and Cy/+ CKD rats (data not
shown). However, we cannot rule out that expression of NHE4
(for which no speciﬁc antibodies exist) or the interstitial con-
centration of ammonium were not altered.
Ammonium excretion and ﬁnal urinary acidiﬁcation are
mediated by the late distal convoluted tubule, connecting tubule
and collecting duct [23]. Type A intercalated cells secrete
protons and ammonia whereas neighbouring segment-speciﬁc
cells (principal cells) also contribute to ammonia secretion [19,
23, 45]. The ﬁnal step of ammonia excretion depends on the
generation of a cortico-papillary gradient of ammonia from in-
terstitium into the lumen of the collecting duct [20, 43].
Ammonia secretion is mediated by the two rhesus proteins
RhBG and RhCG where RhCG appears to play a major role [45,
46]. The driving force for ammonia secretion, however, depends
on the degree of urinary acidiﬁcation by Type A intercalated
cells. The importance of acid–base transport proteins in these
cells is highlighted by inherited disorders in humans with muta-
tions in the AE1/SLC4A1 chloride/bicarbonate exchanger, and
the B1/ATP6V1B1 and a4/ATP6V0A4 H+-ATPase subunits
[47–50]. Urinary pH was more acidic in cy/+ CKD rats under
baseline conditions and was further acidiﬁed after the HCl diet
demonstrating an intact capacity to generate and maintain a
steep proton gradient from interstitium to the collecting duct
lumen. Surprisingly, AE1 mRNA and protein abundance was
decreased in CKD animals whereas the abundance of the B1
H+-ATPase subunit remained unaltered. Thus, the maximal
capacity of the collecting duct to maximally acidify urine may
be decreased; however, in the presence of greatly reduced
ammonia concentrations urinary pH remains very acidic. The
reduced expression of pendrin, a marker of non-Type A interca-
lated cells, is most likely caused by metabolic acidosis [29, 51,
52]. Impaired ammonia secretion by the collecting duct may
not only be the result of decreased proximal tubular ammonia-
genesis but also due to lower expression of the ammonia trans-
porter RhCG. Thus, reduced secretion of ammonia by the
collecting duct is likely by a combination of decreased ammo-
niagenesis and reduced RhCG expression. The reason for lower
RhCG expression is not known and may be either the direct
consequence of renal disease or a response to reduced
F IGURE 6 : Regulation of mRNA abundance of collecting duct acid–base transporters. Normalized mRNA abundance of AE1, pendrin, RhCG
and B1 subunit of the H+-ATPase are shown in controls and CKD rats (cy/+) on standard diet and after 2 days of acid load with HCl. n = 5–6
per group, *P < 0.05, **P < 0.01, ***P < 0.001 signiﬁcantly different between wild-type and CKD rats (cy/+).
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ammoniagenesis. Similarly, in a mouse model with haploinsuf-
ﬁciency of Rhcg, reduced urinary acid excretion was observed
indicating that low levels of RhCG expression per semay reduce
renal acid excretion [45].
Renal reabsorption of phosphate is reduced
in Han:SPRD rats
Efﬁcient proton secretion depends in part on the availability
of titratable acids, mostly phosphate, that buffer protons and
thereby prevent an excessive urinary acidiﬁcation that would
impair further acid excretion [39, 49]. In metabolic acidosis,
phosphate excretion is increased to increase buffer capacity and
to reduce extracellular phosphate derived from bone [53]. Phos-
phate excretion in the kidney is mainly controlled by reabsorp-
tion of phosphate in the proximal tubule mediated by a set of
sodium-dependent transporter, namely NaPi-IIa and NaPi-IIc
[32]. Protein abundance of NaPi-IIc but not of NaPi-IIa was
down-regulated in CKD rats after HCl load. Urinary phos-
phate excretion was higher after acid loading. Moreover, CKD
rats had increased phosphaturia under normal conditions that
was paralleled by reduced expression of NaPi-IIc but not
NaPi-IIa. Thus, phosphaturia under these conditions may
result from a combination of direct inhibition of NaPi-IIa and
NaPi-IIc transport activity by lower urinary pH in the prox-
imal tubule due to lower plasma bicarbonate levels and the
down-regulation of NaPi-IIc [39]. The up-regulation of Pit-2
abundance in acid-loaded cy/+ rats may reﬂect a compensa-
tory mechanism to limit urinary phosphate losses.
In conclusion, we demonstrated that renal ammonium ex-
cretion is severely impaired in a CKD rat model while urinary
acidiﬁcation is mostly preserved. The expression of key mole-
cules of the ammoniagenesis pathway in the proximal tubule
and the excretory ammonium transporter RhCG is reduced in
kidney. Whether the reduced number of functional nephrons
and/or the down-regulation of these molecules cause the renal
acidosis in CKD remains to be further explored.
SUPPLEMENTARY DATA
Supplementary data are available online at http://ndt.oxford
journals.org.
F IGURE 7 : Reduced expression of the ammonia transporters RhCG. Protein abundance of AE1, pendrin, RhCG and the B1 subunit of the H+-
ATPase are shown in controls and CKD rats (cy/+) on standard diet and after 2 days of acid load with HCl. The immunoblots were stripped and
re-probed for all proteins and β-actin. All data were normalized against β-actin. n = 5–6 per group, *P < 0.05, **P < 0.01, ***P < 0.001 signiﬁcantly
different between wild-type and CKD rats (cy/+).
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Diabetic nephropathy is associated with increased urine
excretion of proteases plasmin, prostasin and urokinase and
activation of amiloride-sensitive current in collecting duct cells
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ABSTRACT
Background. Diabetic nephropathy (DN) is associated with
hypertension, expanded extracellular volume and impaired
renal Na+ excretion. It was hypothesized that aberrant glom-
erular ﬁltration of serine proteases in DN causes proteolytic
activation of the epithelial sodium channel (ENaC) in the
kidney by excision of an inhibitory peptide tract from the γ
subunit.
Methods. In a cross-sectional design, urine, plasma and clinic-
al data were collected from type 1 diabetic patients with DN
(n = 19) and matched normoalbuminuric type 1 diabetics
(controls, n = 20). Urine was examined for proteases by
western immunoblotting, patch clamp and ELISA. Urine exo-
somes were isolated to elucidate potential cleavage of γENaC
by a monoclonal antibody directed against the ‘inhibitory’
peptide tract.
Results. Compared with control, DN patients displayed sig-
niﬁcantly higher blood pressure and urinary excretion of
plasmin(ogen), prostasin and urokinase that correlated direct-
ly with urine albumin. Western blotting conﬁrmed plasmin,
prostasin and urokinase in urine from the DN group predom-
inantly. Urine from DN evoked a signiﬁcantly larger amilor-
ide-sensitive inward current in single collecting duct cells
compared with controls. Immunoblotting of urine exosomes
showed aquaporin 2 in all patient samples. Exosomes dis-
played a virtual absence of intact γENaC while moieties com-
patible with cleavage by furin only, were shown in both
groups. Proteolytic cleavage by the extracellular serine pro-
teases plasmin or prostasin was observed in DN samples pre-
dominantly.
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